vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.
UNITY BANCORP INC is the larger business by last-quarter revenue ($35.3M vs $31.1M, roughly 1.1× LIFECORE BIOMEDICAL, INC. \DE\). UNITY BANCORP INC runs the higher net margin — 43.9% vs -32.1%, a 76.0% gap on every dollar of revenue. On growth, UNITY BANCORP INC posted the faster year-over-year revenue change (24.2% vs -4.5%). UNITY BANCORP INC produced more free cash flow last quarter ($44.3M vs $25.0K). Over the past eight quarters, UNITY BANCORP INC's revenue compounded faster (17.5% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.
LFCR vs UNTY — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $35.3M |
| Net Profit | $-10.0M | $15.5M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | 55.8% |
| Net Margin | -32.1% | 43.9% |
| Revenue YoY | -4.5% | 24.2% |
| Net Profit YoY | -52.0% | 34.5% |
| EPS (diluted) | $-0.29 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $35.3M | ||
| Q3 25 | $31.1M | $32.8M | ||
| Q2 25 | — | $34.4M | ||
| Q1 25 | $35.2M | $29.4M | ||
| Q4 24 | $32.6M | $28.4M | ||
| Q3 24 | $24.7M | $27.7M | ||
| Q2 24 | — | $25.5M | ||
| Q1 24 | $35.7M | $25.6M |
| Q4 25 | — | $15.5M | ||
| Q3 25 | $-10.0M | $14.4M | ||
| Q2 25 | — | $16.5M | ||
| Q1 25 | $-14.8M | $11.6M | ||
| Q4 24 | $-6.6M | $11.5M | ||
| Q3 24 | $-16.2M | $10.9M | ||
| Q2 24 | — | $9.5M | ||
| Q1 24 | $15.6M | $9.6M |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | 55.8% | ||
| Q3 25 | -9.9% | 57.5% | ||
| Q2 25 | — | 62.6% | ||
| Q1 25 | -25.7% | 52.6% | ||
| Q4 24 | -6.0% | 51.0% | ||
| Q3 24 | -46.9% | 52.7% | ||
| Q2 24 | — | 49.3% | ||
| Q1 24 | -2.5% | 50.0% |
| Q4 25 | — | 43.9% | ||
| Q3 25 | -32.1% | 43.8% | ||
| Q2 25 | — | 48.0% | ||
| Q1 25 | -42.0% | 39.5% | ||
| Q4 24 | -20.2% | 40.5% | ||
| Q3 24 | -65.7% | 39.4% | ||
| Q2 24 | — | 37.1% | ||
| Q1 24 | 43.8% | 37.5% |
| Q4 25 | — | $1.52 | ||
| Q3 25 | $-0.29 | $1.41 | ||
| Q2 25 | — | $1.61 | ||
| Q1 25 | $-0.47 | $1.13 | ||
| Q4 24 | $-0.25 | $1.13 | ||
| Q3 24 | $-0.53 | $1.07 | ||
| Q2 24 | — | $0.92 | ||
| Q1 24 | $0.42 | $0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | — |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $345.6M |
| Total Assets | $235.2M | $3.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $18.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $9.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | $230.8M | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $345.6M | ||
| Q3 25 | $-10.5M | $334.0M | ||
| Q2 25 | — | $319.8M | ||
| Q1 25 | $2.2M | $306.1M | ||
| Q4 24 | $15.4M | $295.6M | ||
| Q3 24 | $-3.9M | $284.3M | ||
| Q2 24 | — | $273.4M | ||
| Q1 24 | $17.7M | $266.8M |
| Q4 25 | — | $3.0B | ||
| Q3 25 | $235.2M | $2.9B | ||
| Q2 25 | — | $2.9B | ||
| Q1 25 | $237.7M | $2.8B | ||
| Q4 24 | $255.4M | $2.7B | ||
| Q3 24 | $246.8M | $2.6B | ||
| Q2 24 | — | $2.6B | ||
| Q1 24 | $246.2M | $2.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $44.9M |
| Free Cash FlowOCF − Capex | $25.0K | $44.3M |
| FCF MarginFCF / Revenue | 0.1% | 125.7% |
| Capex IntensityCapex / Revenue | 5.6% | 1.6% |
| Cash ConversionOCF / Net Profit | — | 2.90× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $81.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $44.9M | ||
| Q3 25 | $1.8M | $45.5M | ||
| Q2 25 | — | $-25.3M | ||
| Q1 25 | $1.2M | $17.9M | ||
| Q4 24 | $-6.1M | $48.0M | ||
| Q3 24 | $-613.0K | $17.7M | ||
| Q2 24 | — | $-8.4M | ||
| Q1 24 | $-1.4M | $15.8M |
| Q4 25 | — | $44.3M | ||
| Q3 25 | $25.0K | $45.3M | ||
| Q2 25 | — | $-25.5M | ||
| Q1 25 | $-4.3M | $17.6M | ||
| Q4 24 | $-8.6M | $47.3M | ||
| Q3 24 | $-4.0M | $17.5M | ||
| Q2 24 | — | $-8.6M | ||
| Q1 24 | $-7.8M | $15.7M |
| Q4 25 | — | 125.7% | ||
| Q3 25 | 0.1% | 138.1% | ||
| Q2 25 | — | -74.2% | ||
| Q1 25 | -12.1% | 59.9% | ||
| Q4 24 | -26.3% | 166.5% | ||
| Q3 24 | -16.3% | 63.3% | ||
| Q2 24 | — | -33.7% | ||
| Q1 24 | -21.8% | 61.4% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | 5.6% | 0.7% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | 15.5% | 1.0% | ||
| Q4 24 | 7.5% | 2.4% | ||
| Q3 24 | 13.9% | 0.5% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | 17.8% | 0.3% |
| Q4 25 | — | 2.90× | ||
| Q3 25 | — | 3.16× | ||
| Q2 25 | — | -1.54× | ||
| Q1 25 | — | 1.54× | ||
| Q4 24 | — | 4.17× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | -0.89× | ||
| Q1 24 | -0.09× | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
UNTY
Segment breakdown not available.
